Delcath Systems, Inc. (DCTH) stock
Close on Nov 18, 2026Market cap $683.57MP/E 1970.0Yield –
Earnings
Delcath Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Delcath Systems's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 9, 2026before the open | $35.10M | +70.4% | $0.17 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $29.10M | +20.2% | $0.07 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026before the open | $25.00M | +26.3% | -$0.03 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $20.70M | +37.1% | -$0.05 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | $20.60M | +83.9% | $0.02 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025before the open | $24.20M | +210.3% | $0.07 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | $19.80M | +538.7% | $0.03 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025before the open | $15.10M | +2920.0% | -$0.11 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 8, 2024before the open | $11.20M | +2700.0% | $0.06 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 5, 2024after the close | $7.80M | +1460.0% | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | $3.10M | +416.7% | -$0.45 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 26, 2024before the open | $500.00K | – | -$0.48 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | $400.00K | – | -$1.14 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023after the close | $500.00K | – | -$0.58 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023before the open | $600.00K | +100.0% | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 27, 2023after the close | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022during market hours | $300.00K | – | -$1.00 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 29, 2022after the close | $200.00K | – | -$0.69 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | $522.00K | – | -$0.94 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 11, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 1, 2021after the close | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 18, 2020during market hours | – | – | – | Filing |
| Q4 FY2015ended Dec 31, 2015 | Mar 23, 2016after the close | – | – | – | Filing |
| Q4 FY2014ended Dec 31, 2014 | Mar 11, 2015after the close | – | – | – | Filing |
| Q3 FY2014ended Sep 30, 2014 | Nov 6, 2014after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Delcath Systems's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total HEPZATO KIT and CHEMOSAT revenue | FY2026 | $115.00M – $117.00M | $100.00M | Raised | Nov 9, 2026 |
| Total HEPZATO KIT and CHEMOSAT revenue | FY2026 | $104.00M – $108.00M | $100.00M | Raised | Aug 6, 2026 |
| Full year gross margins | FY2026 | 86% – 89% | 84% – 87% | Raised | Aug 6, 2026 |
| gross margins | FY2026 | 87% – 89% | 84% – 87% | Raised | Nov 9, 2026 |
Guidance vs results
The last range Delcath Systems gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $83.00M – $85.00M | $85.30MΣ4Q | Above range |
Guidance history
Every forecast Delcath Systems put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 9, 2026 | gross margins | FY2026 | 87% – 89% | Raised |
| Nov 9, 2026 | Total HEPZATO KIT and CHEMOSAT revenue | FY2026 | $115.00M – $117.00M | Raised |
| Aug 6, 2026 | Full year gross margins | FY2026 | 86% – 89% | Raised |
| Aug 6, 2026 | Total HEPZATO KIT and CHEMOSAT revenue | FY2026 | $104.00M – $108.00M | Raised |
| May 7, 2026 | Gross margins | FY2026 | 84% – 87% | New |
| May 7, 2026 | Total CHEMOSAT and HEPZATO KIT revenue | FY2026 | $100.00M | New |
| Feb 26, 2026 | Gross margins | FY2026 | 84% – 87% | New |
| Feb 26, 2026 | Total CHEMOSAT and HEPZATO KIT revenue | FY2026 | $100.00M | New |
| Nov 4, 2025 | Gross margins | FY2025 | 85% – 87% | Reaffirmed |
| Nov 4, 2025 | Total CHEMOSAT and HEPZATO KIT revenue | FY2025 | $83.00M – $85.00M | Lowered |
| Oct 20, 2025 | Quarterly gross margins | FY2025 | 85% – 87% | Raised |
| Oct 20, 2025 | Total CHEMOSAT and HEPZATO KIT revenue | FY2025 | $83.00M – $85.00M | New |
| Aug 6, 2025 | Gross margins | FY2025 | 83% – 85% | New |
| Aug 6, 2025 | Total CHEMOSAT and HEPZATO KIT revenue | FY2025 | $93.00M – $96.00M | New |
| May 14, 2024 | active centers | FY2024 | 20 | Reaffirmed |
| Mar 26, 2024 | site activation guidance | FY2024 | 20 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Delcath Systems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?